Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Socié, Gérard  [Clear All Filters]
2014
van Laar, J.M., Farge, D., Sont, J.K., Naraghi, K., Marjanovic, Z., Larghero, J., Schuerwegh, A.J., Marijt, E.W.A., Vonk, M.C., Schattenberg, A.V., et al. (2014). Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis: A Randomized Clinical Trial.Jama311, 2490-2498.
Itzykson, R., Robin, M., Moins-Teisserenc, H., Delord, M., Busson, M., Xhaard, A., de Fontbrune, F.Sicre, de Latour, R.Peffault, Toubert, A., and Socié, G. (2014). Cytomegalovirus shapes long-term immune reconstitution after allogeneic stem cell transplantation.Haematologica.
Brüggen, M.-C., Petzelbauer, P., Greinix, H., Contassot, E., Jankovic, D., French, L., Socié, G., Rabitsch, W., Kuzmina, Z., Kalhs, P., et al. (2014). Epidermal Elafin Expression is an Indicator of Poor Prognosis in Cutaneous Graft-versus-Host Disease.J Invest Dermatol.
Loschi, M., Porcher, R., de Latour, R.Peffault, Vanneaux, V., Robin, M., Xhaard, A., de Fontebrune, F.Sicre, Larghero, J., and Socié, G. (2014). High Number of memory T cells is associated with higher risk Of acute GVHD after allogeneic stem cell transplantation.Biol Blood Marrow Transplant.
Glauzy, S., Soret, J., Fournier, I., Douay, C., Moins-Teisserenc, H., de Latour, R.Peffault, Maki, G., Robin, M., Socié, G., Toubert, A., et al. (2014). Impact of acute and chronic Graft-vs-Host Disease on human B-cell generation and replication.Blood.
Meunier, M., Manez, A.-C., Xhaard, A., de Latour, R.Peffault, de Fontbrune, F.Sicre, Dhedin, N., Socié, G., and Robin, M. (2014). Late Donor Bone Marrow Failure After Allogeneic Hematopoietic Stem Cell Transplantation.Transplantation97, e75-e77.
Schlemmer, F., Chevret, S., Lorillon, G., De Bazelaire, C., de Latour, R.Peffault, Meignin, V., Michallet, M., Hermet, E., Wyplosz, B., Houdouin, V., et al. (2014). Late-onset noninfectious interstitial lung disease after allogeneic hematopoietic stem cell transplantation.Respir Med.
Chevallier, P., Labopin, M., Socié, G., Tabrizi, R., Furst, S., Lioure, B., Guillaume, T., Delaunay, J., de la Tour, R.Peffault, Vigouroux, S., et al. (2014). Results from a clofarabine-busulfan containing reduced-toxicity conditioning regimen prior to allogeneic stem cell transplantation: the phase II prospective CLORIC trial.Haematologica.
Brissot, E., Labopin, M., Beckers, M.M., Socié, G., Rambaldi, A., Volin, L., Finke, J., Lenhoff, S., Kröger, N., Ossenkoppele, G.J., et al. (2014). Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia.Haematologica.
2015
Meppiel, E., Crassard, I., de Latour, R.Peffault, de Guibert, S., Terriou, L., Chabriat, H., Socié, G., and Bousser, M.-G. (2015). Cerebral Venous Thrombosis in Paroxysmal Nocturnal Hemoglobinuria: A Series of 15 Cases and Review of the Literature.Medicine (Baltimore)94, e362.
O'Meara, A., Boukouaci, W., Robin, M., Xhaard, A., Fortier, C., Marzais, F., de Fontbrune, F.Sicre, de Latour, R.Peffault, Charron, D., Socié, G., et al. (2015). GLCCI1 and GR genetic diversity and response to glucocorticoid-based treatment of graft-versus-host disease.Biol Blood Marrow Transplant.
Beaussant, Y., Daguindau, E., Pugin, A., Mohty, M., Avet-Loiseau, H., Roos-Weil, D., Michallet, M., Chevalier, P., Raus, N., El-Cheikh, J., et al. (2015). Hematopoietic stem cell transplantation in multiple myeloma. A retrospective study of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).Biol Blood Marrow Transplant.
Brands-Nijenhuis, A.V.M., Labopin, M., Schouten, H.C., Volin, L., Socié, G., Cornelissen, J.J., Huynh, A., Ljungman, P., Malard, F., Esteve, J., et al. (2015). Monosomal karyotype as an adverse prognostic factor in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem-cell transplantation in first complete remission. A retrospective survey on behalf of the ALWP of EBMT.Haematologica.
de Fontbrune, F.Sicre, Galambrun, C., Sirvent, A., Huynh, A., Faguer, S., Nguyen, S., Bay, J.-O., Neven, B., Moussi, J., Simon, L., et al. (2015). Use of Eculizumab in Patients With Allogeneic Stem Cell Transplant-Associated Thrombotic Microangiopathy: A Study From the SFGM-TC.Transplantation.
2018
Chhabra, S., Liu, Y., Hemmer, M.T., Costa, L., Pidala, J.A., Couriel, D.R., Alousi, A.M., Majhail, N.S., Stuart, R.K., Kim, D., et al. (2018). Comparative analysis of calcineurin-inhibitor-based methotrexate and mycophenolate mofetil-containing regimens for prevention of Graft-versus-Host Disease after reduced intensity conditioning allogeneic transplantation.Biol Blood Marrow Transplant.
Tichelli, A., Beohou, E., Labopin, M., Socié, G., Rovó, A., Badoglio, M., van Biezen, A., Bader, P., Duarte, R.F., Basak, G., et al. (2018). Evaluation of Second Solid Cancers After Hematopoietic Stem Cell Transplantation in European Patients.Jama Oncol.
Gilleece, M.H., Labopin, M., Yakoub-Agha, I., Volin, L., Socié, G., Ljungman, P., Huynh, A., Deconinck, E., Wu, D., Bourhis, J.Henri, et al. (2018). Measurable residual disease, conditioning regimen intensity and age predict outcome of allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first remission: a registry analysis of 2292 patients by the Acute Leukemia Working Party Eu.Am J Hematol.
Frick, M., Chan, W., Arends, C.Maximilian, Hablesreiter, R., Halik, A., Heuser, M., Michonneau, D., Blau, O., Hoyer, K., Christen, F., et al. (2018). Role of Donor Clonal Hematopoiesis in Allogeneic Hematopoietic Stem-Cell Transplantation.J Clin OncolJCO2018792184.
Belkacemi, Y., Labopin, M., Giebel, S., Gorin, N.Claude, Loganadane, G., Miszczyk, L., Michallet, M., Socié, G., Schaap, N.Pm, Cornelissen, J.J., et al. (2018). Single Dose Daily Fractionated Is Not Inferior To Twice A Day Fractionated Total Body Irradiation Prior To Allogeneic Stem Cell Transplantation For Acute Leukemia: A Useful Practice Simplification Resulting From The Sarasin Study.Int J Radiat Oncol Biol Phys.
Canaani, J., Beohou, E., Labopin, M., Ghavamzadeh, A., Beelen, D., Hamladji, R.-M., Niederwieser, D., Volin, L., Markiewicz, M., Arnold, R., et al. (2018). Trends in patient outcome over the past two decades following allogeneic stem cell transplantation for acute myeloid leukemia. An ALWP/EBMT analysis.J Intern Med.
Ruggiu, M., Bedossa, P., Rautou, P.Emmanuel, Bertheau, P., Plessier, A., de Latour, R.Peffault, Robin, M., de Fontbrune, F.Sicre, Pagliuca, S., Villate, A., et al. (2018). Utility and safety of liver biopsy in patients with undetermined liver blood test anomalies after allogeneic hematopoietic stem cell transplantation, a monocentric retrospective cohort study.Biol Blood Marrow Transplant.

Pages